Press releases
- Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
- Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
- Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
- Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
- Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
- Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
- Senseonics Holdings, Inc. to Participate in Upcoming Conferences
- Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
- Eversense® CGM System Receives iCGM Designation by the US FDA
More ▼
Key statistics
As of last trade Senseonics Holdings Inc (6L6:DUS) traded at 0.4247, -9.91% below its 52-week high of 0.4714, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4176 |
---|---|
High | 0.4289 |
Low | 0.4137 |
Bid | 0.4241 |
Offer | 0.4313 |
Previous close | 0.4203 |
Average volume | 7.24k |
---|---|
Shares outstanding | 530.89m |
Free float | 493.02m |
P/E (TTM) | -- |
Market cap | 244.63m USD |
EPS (TTM) | -0.1354 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 18:32 BST.
More ▼